Acquisition Adds Extensive Data Science and Technology Capabilities to Trinity’s Growing Commercialization Portfolio
Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the acquisition of Illinois-headquartered D Cube Analytics. The acquisition adds extensive data science and digital transformation capabilities to Trinity’s growing commercialization portfolio. D Cube’s bespoke analytics platforms, purpose built for life sciences companies, help extract maximum value out of data investments and facilitate decision-making to achieve commercial outcomes more effectively and efficiently.
Recommended AI News: Pega Launches Pega Process Extender for Salesforce Lightning on Salesforce App Exchange and Pega Marketplace
“Our strategy to revolutionize the life sciences commercial model includes embracing data science. D Cube brings us high-value, innovative technology platforms that will allow our clients to accelerate their brand strategies,” said David Fitzhenry, CEO of Trinity Life Sciences. “We are excited to add the D Cube team and their best-in-class offerings to our business.”
“The amount of innovation in the life sciences analytics space for the commercialization of products is growing at an exponential rate,” said Neal Dunn, Senior Partner, Analytics. “The D Cube acquisition allows Trinity to accelerate our already growing analytics practice with more deployable technology and proven machine learning models. It also provides Trinity with the scale and tools to help our clients shape and define how and when they should use analytics in a meaningful way – strong analytics will be key to all successful brands.”
“The synergies that D Cube and Trinity share are clear,” said Vijay Nandakumar, co-founder and CEO of D Cube Analytics. “Life sciences companies are at the cusp of a data science revolution where the needs go far beyond clean, transparent and easy-to-manage data. The focus is on insights and speed of responsiveness to market dynamics. Our suite of capabilities combined with Trinity’s strategic therapeutic and commercial expertise offer clients the total package.”
Recommended AI News: Darktrace Adds Early Warning System to Antigena Email
“It was important for us to find a company that had a similar culture as D Cube Analytics and put clients first. Trinity’s purpose – every decision impacts a life – really spoke to us and aligned with our goals,” said Dr. Ajay Chandhok, co-founder and President of D Cube Analytics. “We all know why we get up in the morning – to help life sciences companies make decisions that bring successful life-changing and life-saving treatments to market.”
D Cube Analytics deploys data and cloud agnostic technology that allows life sciences companies not only to integrate, manage and analyze their data but also to focus on quick insights-based decision-making to effectively achieve business outcomes.
With 250+ employees, D Cube Analytics’ senior leadership (including Mr. Nandakumar and Dr. Chandhok) and staff will remain on with Trinity. The acquisition significantly expands Trinity’s India footprint, adding offices in Bengaluru and Chennai.
William Blair acted as exclusive financial advisor, Burke Warren acted as legal counsel and Vertices Partners acted as India Counsel for D Cube Analytics.
Recommended AI News: Tyson & Blake makes Follow-on Investment in StrongRoom AI “SRAI”
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.